.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Novartis
McKesson
Covington
Medtronic
Dow
US Department of Justice
Merck
Chinese Patent Office

Generated: July 28, 2017

DrugPatentWatch Database Preview

VELPHORO Drug Profile

« Back to Dashboard

What is the patent landscape for Velphoro, and when can generic versions of Velphoro launch?

Velphoro is a drug marketed by Vifor Fresenius and is included in one NDA. There are two patents protecting this drug.

This drug has sixty patent family members in thirty-five countries.

The generic ingredient in VELPHORO is sucroferric oxyhydroxide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sucroferric oxyhydroxide profile page.

Summary for Tradename: VELPHORO

Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list2
Drug Prices:see details
DailyMed Link:VELPHORO at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vifor Fresenius
VELPHORO
sucroferric oxyhydroxide
TABLET, CHEWABLE;ORAL205109-001Nov 27, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Vifor Fresenius
VELPHORO
sucroferric oxyhydroxide
TABLET, CHEWABLE;ORAL205109-001Nov 27, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Vifor Fresenius
VELPHORO
sucroferric oxyhydroxide
TABLET, CHEWABLE;ORAL205109-001Nov 27, 2013RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: VELPHORO

Country Document Number Estimated Expiration
Austria207707► Subscribe
Mexico2010005346► Subscribe
Argentina005026► Subscribe
Malaysia156383► Subscribe
Slovenia868125► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.



Supplementary Protection Certificates for Tradename: VELPHORO

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0018France► SubscribePRODUCT NAME: MELANGE D'OXYHYDROXYDE DE FER (III) POLYNUCLEAIRE,DE SACCHAROSE ET D'AMIDONS.; REGISTRATION NO/DATE: EU/1/14/943/001 20140826
5Finland► Subscribe
00710Netherlands► SubscribePRODUCT NAME: MENGSEL VAN POLYNUCLEAIRE IJZER (III)-OXYHYDROXIDE, SUCROSE EN ZETMEEL; REGISTRATION NO/DATE: EU/1/14/943 20140826
2015 00007Denmark► SubscribePRODUCT NAME: BLANDING AF POLYNUKLEAERT JERN(III)-OXYHYDROXID, SUCROSE OG STIVELSE; REG. NO/DATE: EU/1/14/943/001-004 20140826
C/GB14/087United Kingdom► SubscribePRODUCT NAME: MIXTURE OF POLYNUCLEAR IRON(III)OXYHYDROXIDE, SUCROSE AND STARCHES; REGISTERED: UK EU/1/14/943/001 20140828; UK EU/1/14/943/002 20140828; UK EU/1/14/943/003 20140828; UK EU/1/14/943/004 20140828
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Citi
Daiichi Sankyo
UBS
QuintilesIMS
Deloitte
Johnson and Johnson
Accenture
Argus Health
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot